APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Decommissioning Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Decommissioning Service Market Outlook and Growth Opportunities 2026

16 April 2026Not stated

Choose your research edition.

Industry ResearchPharmaceutical Decommissioning Service Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Decommissioning Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Decommissioning Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Decommissioning Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Decommissioning Service Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global Pharmaceutical Decommissioning Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Decommissioning Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Decommissioning Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Decommissioning Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Decommissioning Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Decommissioning Service market include KDC Veolia, RCS Pharma, Technical Safety Services, ISPE, Brilliant Equipment Services, Qualitech Environmental Services, Hughes & Salvidge, Divestiture and Pharmagraph, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical Decommissioning Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Decommissioning Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Decommissioning Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Decommissioning Service market.

Pharmaceutical Decommissioning Service Segment by Company

KDC Veolia

RCS Pharma

Technical Safety Services

ISPE

Brilliant Equipment Services

Qualitech Environmental Services

Hughes & Salvidge

Divestiture

Pharmagraph

RVA Group

DSM Demolition

KERAMIDA Inc

Downwell Enabling Solutions

Pharmaceutical Decommissioning Service Segment by Type

Equipment Decommissioning Service

Facility Decommissioning Service

Laboratory Decommissioning Service

Others

Pharmaceutical Decommissioning Service Segment by Application

Pharmaceutical Manufacturers

Pharmaceutical CDMO

Pharmaceutical Decommissioning Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Decommissioning Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Decommissioning Service key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Decommissioning Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Decommissioning Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Decommissioning Service significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Decommissioning Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Decommissioning Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Decommissioning Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Decommissioning Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Decommissioning Service industry.

Chapter 3: Detailed analysis of Pharmaceutical Decommissioning Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Decommissioning Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Decommissioning Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Decommissioning Service Industry Trends Table 2. Pharmaceutical Decommissioning Service Industry Drivers Table 3. Pharmaceutical Decommissioning Service Industry Opportunities and Challenges Table 4. Pharmaceutical Decommissioning Service Industry Restraints Table 5. Global Pharmaceutical Decommissioning Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Decommissioning Service Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Decommissioning Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Decommissioning Service Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Decommissioning Service Company, Product Type & Application Table 10. Global Pharmaceutical Decommissioning Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Decommissioning Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Equipment Decommissioning Service Table 15. Significant Companies of Facility Decommissioning Service Table 16. Significant Companies of Laboratory Decommissioning Service Table 17. Significant Companies of Others Table 18. Global Pharmaceutical Decommissioning Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pharmaceutical Decommissioning Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pharmaceutical Decommissioning Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical Decommissioning Service Sales Value Share by Type (2021-2026) Table 22. Global Pharmaceutical Decommissioning Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical Manufacturers Table 24. Significant Companies of Pharmaceutical CDMO Table 25. Global Pharmaceutical Decommissioning Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmaceutical Decommissioning Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Pharmaceutical Decommissioning Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Pharmaceutical Decommissioning Service Sales Value Share by Application (2021-2026) Table 29. Global Pharmaceutical Decommissioning Service Sales Value Share by Application (2027-2032) Table 30. Global Pharmaceutical Decommissioning Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharmaceutical Decommissioning Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Pharmaceutical Decommissioning Service Sales Value Share by Region (2021-2026) Table 33. Global Pharmaceutical Decommissioning Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Pharmaceutical Decommissioning Service Sales Value Share by Region (2027-2032) Table 35. Global Pharmaceutical Decommissioning Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pharmaceutical Decommissioning Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Pharmaceutical Decommissioning Service Sales Value Market Share by Country (2021-2026) Table 38. Global Pharmaceutical Decommissioning Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Pharmaceutical Decommissioning Service Sales Value Market Share by Country (2027-2032) Table 40. KDC Veolia Company Information Table 41. KDC Veolia Business Overview Table 42. KDC Veolia Pharmaceutical Decommissioning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. KDC Veolia Pharmaceutical Decommissioning Service Product Portfolio Table 44. KDC Veolia Recent Development Table 45. RCS Pharma Company Information Table 46. RCS Pharma Business Overview Table 47. RCS Pharma Pharmaceutical Decommissioning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. RCS Pharma Pharmaceutical Decommissioning Service Product Portfolio Table 49. RCS Pharma Recent Development Table 50. Technical Safety Services Company Information Table 51. Technical Safety Services Business Overview Table 52. Technical Safety Services Pharmaceutical Decommissioning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Technical Safety Services Pharmaceutical Decommissioning Service Product Portfolio Table 54. Technical Safety Services Recent Development Table 55. ISPE Company Information Table 56. ISPE Business Overview Table 57. ISPE Pharmaceutical Decommissioning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. ISPE Pharmaceutical Decommissioning Service Product Portfolio Table 59. ISPE Recent Development Table 60. Brilliant Equipment Services Company Information Table 61. Brilliant Equipment Services Business Overview Table 62. Brilliant Equipment Services Pharmaceutical Decommissioning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Brilliant Equipment Services Pharmaceutical Decommissioning Service Product Portfolio Table 64. Brilliant Equipment Services Recent Development Table 65. Qualitech Environmental Services Company Information Table 66. Qualitech Environmental Services Business Overview Table 67. Qualitech Environmental Services Pharmaceutical Decommissioning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Qualitech Environmental Services Pharmaceutical Decommissioning Service Product Portfolio Table 69. Qualitech Environmental Services Recent Development Table 70. Hughes & Salvidge Company Information Table 71. Hughes & Salvidge Business Overview Table 72. Hughes & Salvidge Pharmaceutical Decommissioning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Hughes & Salvidge Pharmaceutical Decommissioning Service Product Portfolio Table 74. Hughes & Salvidge Recent Development Table 75. Divestiture Company Information Table 76. Divestiture Business Overview Table 77. Divestiture Pharmaceutical Decommissioning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Divestiture Pharmaceutical Decommissioning Service Product Portfolio Table 79. Divestiture Recent Development Table 80. Pharmagraph Company Information Table 81. Pharmagraph Business Overview Table 82. Pharmagraph Pharmaceutical Decommissioning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Pharmagraph Pharmaceutical Decommissioning Service Product Portfolio Table 84. Pharmagraph Recent Development Table 85. RVA Group Company Information Table 86. RVA Group Business Overview Table 87. RVA Group Pharmaceutical Decommissioning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. RVA Group Pharmaceutical Decommissioning Service Product Portfolio Table 89. RVA Group Recent Development Table 90. DSM Demolition Company Information Table 91. DSM Demolition Business Overview Table 92. DSM Demolition Pharmaceutical Decommissioning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. DSM Demolition Pharmaceutical Decommissioning Service Product Portfolio Table 94. DSM Demolition Recent Development Table 95. KERAMIDA Inc Company Information Table 96. KERAMIDA Inc Business Overview Table 97. KERAMIDA Inc Pharmaceutical Decommissioning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. KERAMIDA Inc Pharmaceutical Decommissioning Service Product Portfolio Table 99. KERAMIDA Inc Recent Development Table 100. Downwell Enabling Solutions Company Information Table 101. Downwell Enabling Solutions Business Overview Table 102. Downwell Enabling Solutions Pharmaceutical Decommissioning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Downwell Enabling Solutions Pharmaceutical Decommissioning Service Product Portfolio Table 104. Downwell Enabling Solutions Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Pharmaceutical Decommissioning Service Product Image Figure 2. Global Pharmaceutical Decommissioning Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Decommissioning Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Decommissioning Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Equipment Decommissioning Service Image Figure 8. Facility Decommissioning Service Image Figure 9. Laboratory Decommissioning Service Image Figure 10. Others Image Figure 11. Global Pharmaceutical Decommissioning Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmaceutical Decommissioning Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Decommissioning Service Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical Manufacturers Image Figure 15. Pharmaceutical CDMO Image Figure 16. Global Pharmaceutical Decommissioning Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pharmaceutical Decommissioning Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pharmaceutical Decommissioning Service Sales Value Share by Application (2021-2032) Figure 19. Global Pharmaceutical Decommissioning Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pharmaceutical Decommissioning Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Pharmaceutical Decommissioning Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Pharmaceutical Decommissioning Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Pharmaceutical Decommissioning Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Pharmaceutical Decommissioning Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Pharmaceutical Decommissioning Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Pharmaceutical Decommissioning Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Pharmaceutical Decommissioning Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Pharmaceutical Decommissioning Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Pharmaceutical Decommissioning Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Pharmaceutical Decommissioning Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Equipment Decommissioning Service
  • Facility Decommissioning Service
  • Laboratory Decommissioning Service
  • Others
Applications
  • Pharmaceutical Manufacturers
  • Pharmaceutical CDMO
Companies covered
  • KDC Veolia
  • RCS Pharma
  • Technical Safety Services
  • ISPE
  • Brilliant Equipment Services
  • Qualitech Environmental Services
  • Hughes & Salvidge
  • Divestiture
  • Pharmagraph
  • RVA Group
  • DSM Demolition
  • KERAMIDA Inc
  • Downwell Enabling Solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Decommissioning Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Decommissioning Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Decommissioning Service Market Dynamics
  1. 2.1 Pharmaceutical Decommissioning Service Industry Trends
  2. 2.2 Pharmaceutical Decommissioning Service Industry Drivers
  3. 2.3 Pharmaceutical Decommissioning Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Decommissioning Service Industry Restraints
3 Pharmaceutical Decommissioning Service Market by Company
  1. 3.1 Global Pharmaceutical Decommissioning Service Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Decommissioning Service Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Decommissioning Service Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Decommissioning Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Decommissioning Service Company Product Type and Application
  6. 3.6 Global Pharmaceutical Decommissioning Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Decommissioning Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Decommissioning Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Decommissioning Service Market by Type
  1. 4.1 Pharmaceutical Decommissioning Service Type Introduction
  2. 4.1.1 Equipment Decommissioning Service
  3. 4.1.2 Facility Decommissioning Service
  4. 4.1.3 Laboratory Decommissioning Service
  5. 4.1.4 Others
  6. 4.2 Global Pharmaceutical Decommissioning Service Sales Value by Type
  7. 4.2.1 Global Pharmaceutical Decommissioning Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmaceutical Decommissioning Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pharmaceutical Decommissioning Service Sales Value Share by Type (2021-2032)
5 Pharmaceutical Decommissioning Service Market by Application
  1. 5.1 Pharmaceutical Decommissioning Service Application Introduction
  2. 5.1.1 Pharmaceutical Manufacturers
  3. 5.1.2 Pharmaceutical CDMO
  4. 5.2 Global Pharmaceutical Decommissioning Service Sales Value by Application
  5. 5.2.1 Global Pharmaceutical Decommissioning Service Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pharmaceutical Decommissioning Service Sales Value by Application (2021-2032)
  7. 5.2.3 Global Pharmaceutical Decommissioning Service Sales Value Share by Application (2021-2032)
6 Pharmaceutical Decommissioning Service Regional Value Analysis
  1. 6.1 Global Pharmaceutical Decommissioning Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Decommissioning Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Decommissioning Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Decommissioning Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Decommissioning Service Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Decommissioning Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Decommissioning Service Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Decommissioning Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Decommissioning Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Decommissioning Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Decommissioning Service Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Decommissioning Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Decommissioning Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Decommissioning Service Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Decommissioning Service Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Decommissioning Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Decommissioning Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Decommissioning Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Decommissioning Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Decommissioning Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Decommissioning Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Decommissioning Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 KDC Veolia
  2. 8.1.1 KDC Veolia Company Information
  3. 8.1.2 KDC Veolia Business Overview
  4. 8.1.3 KDC Veolia Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 KDC Veolia Pharmaceutical Decommissioning Service Product Portfolio
  6. 8.1.5 KDC Veolia Recent Developments
  7. 8.2 RCS Pharma
  8. 8.2.1 RCS Pharma Company Information
  9. 8.2.2 RCS Pharma Business Overview
  10. 8.2.3 RCS Pharma Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 RCS Pharma Pharmaceutical Decommissioning Service Product Portfolio
  12. 8.2.5 RCS Pharma Recent Developments
  13. 8.3 Technical Safety Services
  14. 8.3.1 Technical Safety Services Company Information
  15. 8.3.2 Technical Safety Services Business Overview
  16. 8.3.3 Technical Safety Services Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Technical Safety Services Pharmaceutical Decommissioning Service Product Portfolio
  18. 8.3.5 Technical Safety Services Recent Developments
  19. 8.4 ISPE
  20. 8.4.1 ISPE Company Information
  21. 8.4.2 ISPE Business Overview
  22. 8.4.3 ISPE Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ISPE Pharmaceutical Decommissioning Service Product Portfolio
  24. 8.4.5 ISPE Recent Developments
  25. 8.5 Brilliant Equipment Services
  26. 8.5.1 Brilliant Equipment Services Company Information
  27. 8.5.2 Brilliant Equipment Services Business Overview
  28. 8.5.3 Brilliant Equipment Services Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Brilliant Equipment Services Pharmaceutical Decommissioning Service Product Portfolio
  30. 8.5.5 Brilliant Equipment Services Recent Developments
  31. 8.6 Qualitech Environmental Services
  32. 8.6.1 Qualitech Environmental Services Company Information
  33. 8.6.2 Qualitech Environmental Services Business Overview
  34. 8.6.3 Qualitech Environmental Services Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Qualitech Environmental Services Pharmaceutical Decommissioning Service Product Portfolio
  36. 8.6.5 Qualitech Environmental Services Recent Developments
  37. 8.7 Hughes & Salvidge
  38. 8.7.1 Hughes & Salvidge Company Information
  39. 8.7.2 Hughes & Salvidge Business Overview
  40. 8.7.3 Hughes & Salvidge Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hughes & Salvidge Pharmaceutical Decommissioning Service Product Portfolio
  42. 8.7.5 Hughes & Salvidge Recent Developments
  43. 8.8 Divestiture
  44. 8.8.1 Divestiture Company Information
  45. 8.8.2 Divestiture Business Overview
  46. 8.8.3 Divestiture Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Divestiture Pharmaceutical Decommissioning Service Product Portfolio
  48. 8.8.5 Divestiture Recent Developments
  49. 8.9 Pharmagraph
  50. 8.9.1 Pharmagraph Company Information
  51. 8.9.2 Pharmagraph Business Overview
  52. 8.9.3 Pharmagraph Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pharmagraph Pharmaceutical Decommissioning Service Product Portfolio
  54. 8.9.5 Pharmagraph Recent Developments
  55. 8.10 RVA Group
  56. 8.10.1 RVA Group Company Information
  57. 8.10.2 RVA Group Business Overview
  58. 8.10.3 RVA Group Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 RVA Group Pharmaceutical Decommissioning Service Product Portfolio
  60. 8.10.5 RVA Group Recent Developments
  61. 8.11 DSM Demolition
  62. 8.11.1 DSM Demolition Company Information
  63. 8.11.2 DSM Demolition Business Overview
  64. 8.11.3 DSM Demolition Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 DSM Demolition Pharmaceutical Decommissioning Service Product Portfolio
  66. 8.11.5 DSM Demolition Recent Developments
  67. 8.12 KERAMIDA Inc
  68. 8.12.1 KERAMIDA Inc Company Information
  69. 8.12.2 KERAMIDA Inc Business Overview
  70. 8.12.3 KERAMIDA Inc Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 KERAMIDA Inc Pharmaceutical Decommissioning Service Product Portfolio
  72. 8.12.5 KERAMIDA Inc Recent Developments
  73. 8.13 Downwell Enabling Solutions
  74. 8.13.1 Downwell Enabling Solutions Company Information
  75. 8.13.2 Downwell Enabling Solutions Business Overview
  76. 8.13.3 Downwell Enabling Solutions Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Downwell Enabling Solutions Pharmaceutical Decommissioning Service Product Portfolio
  78. 8.13.5 Downwell Enabling Solutions Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst